Drugs / NPL insulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00641407 | Jan → Dec 2007 | hypoglycemia, type 2 diabetes mellitus | University of Campania Luigi Vanvitelli | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPL insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00641407 ↗ |
| Known as | NPL | “Patients were randomized to either NPL (Lilly) or glargine (Lantus, Aventis)” NCT00641407 ↗ |
| Route | Subcutaneous | “to be administered subcutaneously at bedtime” NCT00641407 ↗ |